Emerging targets of inflammation and tear secretion in dry eye disease
- 1 August 2019
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 24 (8) , 1427-1432
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Rebamipide Suppresses PolyI:C-Stimulated Cytokine Production in Human Conjunctival Epithelial CellsJournal of Ocular Pharmacology and Therapeutics, 2013
- Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eyeJapanese Journal of Ophthalmology, 2013
- Topical diquafosol for patients with obstructive meibomian gland dysfunctionBritish Journal of Ophthalmology, 2013
- A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patientsBritish Journal of Ophthalmology, 2012
- Lacritin, a Novel Human Tear Glycoprotein, Promotes Sustained Basal Tearing and Is Well ToleratedInvestigative Ophthalmology & Visual Science, 2011
- Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cellsPeptides, 2011
- Effects of Cevimeline on the Immunolocalization of Aquaporin-5 and the Ultrastructure of Salivary Glands in Sjögren’s Syndrome Model MiceThe Kurume Medical Journal, 2009
- Rebamipide, a Cytoprotective Drug, Increases Gastric Mucus Secretion in Human: Evaluations with Endoscopic Gastrin TestDigestive Diseases and Sciences, 2008
- Gastroprotective Effects of DA-6034, a New Flavonoid Derivative, in Various Gastric Mucosal Damage ModelsDigestive Diseases and Sciences, 2007
- Ocular Safety of INS365 Ophthalmic Solution: A P2Y 2 Agonist In Healthy SubjectsJournal of Ocular Pharmacology and Therapeutics, 2001